Study to Evaluate Efficacy and Tolerance of R-GemOx in DLBCL and MCL

Last updated on July 2021

Recruitment

Recruitment Status: Completed
Estimated Enrollment: 129

Summary

Conditions

Aggressive Lymphoma
Diffuse Large B Cell Lymphoma
Mantle Cell Lymphoma

Type

Interventional

Phase

Phase 2

Design

Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age: Between 18 years and 125 years
Gender: Both males and females

Description

The purpose of this study is to determine efficacy (overall response rate (ORR) and complete response) tolerance and toxicity of rituximab, gemcitabine, oxaliplatin and dexametasone (R-GemOx) chemotherapy schedule.

Tracking Information

NCT #: NCT01562977
Collaborators: Not Provided
Investigators: Principal Investigator: Andrés López Hernández, MD Hospital Vall d´Hebrón Principal Investigator: Mª Dolores Caballero Barrigón, MD Hospital Clínico de Salamanca Principal Investigator: Jorge Gayoso Cruz, MD Hospital Universitario Gregorio Marañón Principal Investigator: Juan Alfonso Soler Campos, MD Corporació Sanitari Parc Taulí Principal Investigator: Carlos Montalbán Sanz, MD Hospital Universitario Ramon y Cajal Principal Investigator: Juan Manuel Sancho Cía, MD Germans Trias i Pujol Hospital Principal Investigator: Isidro Jarque, MD Hospital La Fe de Valencia Principal Investigator: Secundino Ferrer, MD Hospital Dr. Peset Principal Investigator: Carlos Grande, MD Hospital 12 de Octubre Principal Investigator: Pilar Martínez Barranco, MD Fundación Hospital de Alcorcón Principal Investigator: Miguel Ángel Canales Albendea, MD Hospital La Paz Principal Investigator: Jose Antonio García Marco, MD Hospital Puerta de Hierro de Majadahonda Principal Investigator: Roberto Hernández Martín, MD Hospital Virgen de la Concha Principal Investigator: José Manuel Calvo Villas, MD Hospital Dr. Jose Molina Orosa Principal Investigator: Miguel Hernández, García Hospital Universitario de Canarias Principal Investigator: Elena Pérez Ceballos, MD Hospital Morales Meseguer Principal Investigator: José M. Moraleda Jiménez, MD Hospital Virgen de la Arrixaca Principal Investigator: Eulogio Conde García, MD Hospital Marqués de Valdecilla Principal Investigator: Carlos Panizo Santos, MD Clínica Universitaria Navarra Principal Investigator: Mª Rosario Varela, MD Complejo Hospitalario A Coruña Principal Investigator: Jose Luis Bello López, MD Complejo Hospitalario Universitario de Santiago Principal Investigator: Maria José Ramírez Sánchez, MD Hospital del SAS Jerez Principal Investigator: Luis Palomera, MD Hospital Clínico Lozano Blesa Principal Investigator: Pilar Giraldo, MD Hospital Miguel Servet Principal Investigator: Antonio Gutiérrez, MD Hospital Son Espasses Principal Investigator: Joan Bargay Leonart, MD Hospital Son Llàtzer Principal Investigator: Eva González Barca, MD Hospital Duran i Reynals Principal Investigator: Javier Briones Meijide, MD Hospital Santa Creu i Sant Pau